A team of researchers at the University of Minnesota Medical School recently proved the ability to grow human-derived blood vessels in a pig—a novel approach that has the potential for providing unlimited human vessels for transplant purposes.

Marco Pravetoni, PhD, has been awarded five multi-million dollar grants from the National Institutes of Health to develop novel medical interventions against opioid use disorders and overdose and initiate clinical testing.

Michelle Biros, MD, MS, FACEP, and team perform and consult on the FDA’s exception from informed consent clinical trials that enroll patients during life-threatening situations.

Forum Kamdar, MD, FACC, recently published research that shows duchenne muscular dystrophy heart failure can be modeled with patient-derived stem cells and that beta blockers may be a treatment.

Doug Mashek, PhD, leads a team of researchers who discovered that olive oil in the Mediterranean diet may hold the key to improving lifespan and mitigating aging-related diseases.

Paul A. Iaizzo, PhD, professor with the Visible Heart Laboratories, and his team provide unique educational outreach that impacts individuals around the globe, teaching people all about the human heart.

The U of M increases three spots in Blue Ridge Institute of Medical Research rankings.

Arpit Rao, MBBS, received a two-year grant from the Alliance for Clinical Trials in Oncology to develop a response-adaptive imaging model to predict the best imaging schedule for prostate cancer patients undergoing treatment in clinical trials.

Join the Medical School and College of Pharmacy for a Rare Disease Day program Friday, Feb. 28 at McNamara Alumni Center.

Aaron LeBeau, PhD, is leading groundbreaking prostate cancer research with the support of three active R01 grants from the National Cancer Institute.